Our Understanding of IBD Has Come a Long Way—So Have the Options to Treat It (MedPage Today)

This article highlights the significant progress in treating inflammatory bowel disease (IBD), emphasizing a shift towards a holistic, patient-centered approach. With the increasing role of advanced practice providers (APPs), there is a greater focus on individualized treatment plans that consider the entire patient journey, not just symptom management. The author discusses the evolution of therapies, particularly the use of biologics like STELARA® (ustekinumab), which have demonstrated long-term efficacy and safety in treating Crohn’s disease and ulcerative colitis. The article also covers the importance of multidisciplinary healthcare teams, comprehensive patient assessments, and the need for tailored treatment approaches that align with patient goals and improve quality of life.